Eads, J. R., Olson, D., Pelster, M., Hua, X., Langston, A. A., Shergill, A., Purri, R., Hummel, K., Astrow, S. H., Litten, J. B., Halperin, D. M. (2026). Clinical and translational results from the phase 1 portion of the phase 1/2 study to evaluate CHM-2101, an autologous cadherin 17 (CDH17) chimeric antigen receptor (CAR) T cell therapy for the treatment of relapsed or refractory gastrointestinal cancers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2536